Correlation Between Monte Rosa and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Monopar Therapeutics, you can compare the effects of market volatilities on Monte Rosa and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Monopar Therapeutics.
Diversification Opportunities for Monte Rosa and Monopar Therapeutics
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Monte and Monopar is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Monte Rosa i.e., Monte Rosa and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Monte Rosa and Monopar Therapeutics
Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to under-perform the Monopar Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Monte Rosa Therapeutics is 1.47 times less risky than Monopar Therapeutics. The stock trades about -0.22 of its potential returns per unit of risk. The Monopar Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 2,582 in Monopar Therapeutics on October 21, 2024 and sell it today you would earn a total of 272.00 from holding Monopar Therapeutics or generate 10.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monte Rosa Therapeutics vs. Monopar Therapeutics
Performance |
| Timeline |
| Monte Rosa Therapeutics |
| Monopar Therapeutics |
Monte Rosa and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monte Rosa and Monopar Therapeutics
The main advantage of trading using opposite Monte Rosa and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Monte Rosa vs. Agilent Technologies | Monte Rosa vs. Equillium | Monte Rosa vs. 23Andme Holding Co | Monte Rosa vs. DiaMedica Therapeutics |
| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |